Cancer Biology and Therapeutics

Cancer Immunotherapy & Stem Cell Therapy

The scope of this study entails the current immunologic therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon Alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables. The report also includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials. Stem cell transplant (also called peripheral blood stem cell transplant) is a treatment to try to cure some types of cancer, such as leukemia, lymphoma and myeloma. You have very high doses of chemotherapy, sometimes with whole body radiotherapy. This Session Includes Stem cell mediated immuno gene therapy for tumors, Challenges and new opportunities with antibody drugs, Tumor-host interactions, nuclear responses and tumorigenesis, Cancer Biomarkers, Diagnostic and Prognostic Cancer Biomarkers, Cancer-induced immunosuppressive cells, Immune system stimulation, acquired assistance.